Cargando…
The risk of arterial thrombosis in carriers of natural coagulation inhibitors: a prospective family cohort study
BACKGROUND: Whether the carriership of inherited antithrombin (AT), protein C (PC), and protein S (PS) deficiency increases the risk of arterial thromboembolic events (ATE) is controversial. This information has the potential to inform the management of family members of probands with inherited defi...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195788/ https://www.ncbi.nlm.nih.gov/pubmed/33619677 http://dx.doi.org/10.1007/s11739-021-02656-5 |
_version_ | 1783706566474596352 |
---|---|
author | Tormene, Daniela Noventa, Franco Campello, Elena Gavasso, Sabrina Marobin, Michelangelo Turatti, Giacomo Prandoni, Paolo Simioni, Paolo |
author_facet | Tormene, Daniela Noventa, Franco Campello, Elena Gavasso, Sabrina Marobin, Michelangelo Turatti, Giacomo Prandoni, Paolo Simioni, Paolo |
author_sort | Tormene, Daniela |
collection | PubMed |
description | BACKGROUND: Whether the carriership of inherited antithrombin (AT), protein C (PC), and protein S (PS) deficiency increases the risk of arterial thromboembolic events (ATE) is controversial. This information has the potential to inform the management of family members of probands with inherited deficiency of natural anticoagulants. PATIENTS/METHODS: We conducted a large prospective family cohort study in 640 subjects (of whom 341 carriers and 299 non-carriers) belonging to 86 families with inherited deficiency of AT, PC, or PS. RESULTS: A total of 4240 and 3810 patient-years were available for carriers and non-carriers, respectively. Risk factors for atherosclerosis were similarly distributed in the two groups. Of the 26 ATE that were recorded, 19 occurred in carriers (5.6%), as compared to 7 in non-carriers (2.3%) [p = 0.07]. After adjusting for confounders, the hazard ratio (HR) for ATE was 4.9 (95% CI 1.5–16.3) in carriers as compared to non-carriers. CONCLUSIONS: Among family members of probands with an inherited deficiency of natural anticoagulants, carriers exhibit a risk of ATE that is almost five times higher than in non-carriers. |
format | Online Article Text |
id | pubmed-8195788 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-81957882021-06-28 The risk of arterial thrombosis in carriers of natural coagulation inhibitors: a prospective family cohort study Tormene, Daniela Noventa, Franco Campello, Elena Gavasso, Sabrina Marobin, Michelangelo Turatti, Giacomo Prandoni, Paolo Simioni, Paolo Intern Emerg Med Im - Original BACKGROUND: Whether the carriership of inherited antithrombin (AT), protein C (PC), and protein S (PS) deficiency increases the risk of arterial thromboembolic events (ATE) is controversial. This information has the potential to inform the management of family members of probands with inherited deficiency of natural anticoagulants. PATIENTS/METHODS: We conducted a large prospective family cohort study in 640 subjects (of whom 341 carriers and 299 non-carriers) belonging to 86 families with inherited deficiency of AT, PC, or PS. RESULTS: A total of 4240 and 3810 patient-years were available for carriers and non-carriers, respectively. Risk factors for atherosclerosis were similarly distributed in the two groups. Of the 26 ATE that were recorded, 19 occurred in carriers (5.6%), as compared to 7 in non-carriers (2.3%) [p = 0.07]. After adjusting for confounders, the hazard ratio (HR) for ATE was 4.9 (95% CI 1.5–16.3) in carriers as compared to non-carriers. CONCLUSIONS: Among family members of probands with an inherited deficiency of natural anticoagulants, carriers exhibit a risk of ATE that is almost five times higher than in non-carriers. Springer International Publishing 2021-02-22 2021 /pmc/articles/PMC8195788/ /pubmed/33619677 http://dx.doi.org/10.1007/s11739-021-02656-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Im - Original Tormene, Daniela Noventa, Franco Campello, Elena Gavasso, Sabrina Marobin, Michelangelo Turatti, Giacomo Prandoni, Paolo Simioni, Paolo The risk of arterial thrombosis in carriers of natural coagulation inhibitors: a prospective family cohort study |
title | The risk of arterial thrombosis in carriers of natural coagulation inhibitors: a prospective family cohort study |
title_full | The risk of arterial thrombosis in carriers of natural coagulation inhibitors: a prospective family cohort study |
title_fullStr | The risk of arterial thrombosis in carriers of natural coagulation inhibitors: a prospective family cohort study |
title_full_unstemmed | The risk of arterial thrombosis in carriers of natural coagulation inhibitors: a prospective family cohort study |
title_short | The risk of arterial thrombosis in carriers of natural coagulation inhibitors: a prospective family cohort study |
title_sort | risk of arterial thrombosis in carriers of natural coagulation inhibitors: a prospective family cohort study |
topic | Im - Original |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195788/ https://www.ncbi.nlm.nih.gov/pubmed/33619677 http://dx.doi.org/10.1007/s11739-021-02656-5 |
work_keys_str_mv | AT tormenedaniela theriskofarterialthrombosisincarriersofnaturalcoagulationinhibitorsaprospectivefamilycohortstudy AT noventafranco theriskofarterialthrombosisincarriersofnaturalcoagulationinhibitorsaprospectivefamilycohortstudy AT campelloelena theriskofarterialthrombosisincarriersofnaturalcoagulationinhibitorsaprospectivefamilycohortstudy AT gavassosabrina theriskofarterialthrombosisincarriersofnaturalcoagulationinhibitorsaprospectivefamilycohortstudy AT marobinmichelangelo theriskofarterialthrombosisincarriersofnaturalcoagulationinhibitorsaprospectivefamilycohortstudy AT turattigiacomo theriskofarterialthrombosisincarriersofnaturalcoagulationinhibitorsaprospectivefamilycohortstudy AT prandonipaolo theriskofarterialthrombosisincarriersofnaturalcoagulationinhibitorsaprospectivefamilycohortstudy AT simionipaolo theriskofarterialthrombosisincarriersofnaturalcoagulationinhibitorsaprospectivefamilycohortstudy AT tormenedaniela riskofarterialthrombosisincarriersofnaturalcoagulationinhibitorsaprospectivefamilycohortstudy AT noventafranco riskofarterialthrombosisincarriersofnaturalcoagulationinhibitorsaprospectivefamilycohortstudy AT campelloelena riskofarterialthrombosisincarriersofnaturalcoagulationinhibitorsaprospectivefamilycohortstudy AT gavassosabrina riskofarterialthrombosisincarriersofnaturalcoagulationinhibitorsaprospectivefamilycohortstudy AT marobinmichelangelo riskofarterialthrombosisincarriersofnaturalcoagulationinhibitorsaprospectivefamilycohortstudy AT turattigiacomo riskofarterialthrombosisincarriersofnaturalcoagulationinhibitorsaprospectivefamilycohortstudy AT prandonipaolo riskofarterialthrombosisincarriersofnaturalcoagulationinhibitorsaprospectivefamilycohortstudy AT simionipaolo riskofarterialthrombosisincarriersofnaturalcoagulationinhibitorsaprospectivefamilycohortstudy |